目次

Executive Summary
Market Overview

Market Landscape
Market ecosystem
Value chain analysis

Market Sizing
Market definition
Market segment analysis
Market size 2020
Market outlook: Forecast for 2020 - 2025

Five Forces Analysis
Bargaining power of buyers
Bargaining power of suppliers
Threat of new entrants
Threat of substitutes
Threat of rivalry
Market condition

Market Segmentation by Type
Market segments
Comparison by Type
Biologics - Market size and forecast 2020-2025
Small molecules - Market size and forecast 2020-2025
Market opportunity by Type

Geographic Landscape
Geographic segmentation
Geographic comparison
North America - Market size and forecast 2020-2025
Europe - Market size and forecast 2020-2025
Asia - Market size and forecast 2020-2025
ROW - Market size and forecast 2020-2025
Key leading countries
Market opportunity By Geographical Landscape
Market drivers
Market challenges
Market trends

Vendor Landscape
Vendor landscape
Landscape disruption

Vendor Analysis
Vendors covered
Market positioning of vendors
AFM-Telethon
Biogen Inc.
Brainstorm Cell Therapeutics Inc.
F. Hoffmann-La Roche Ltd.
Mitsubishi Chemical Holdings Corp.
Novartis AG
Pfizer Inc.
PTC Therapeutics Inc.
Sanofi SA
Sarepta Therapeutics Inc.

Appendix
Scope of the report
Currency conversion rates for US$
Research methodology
List of abbreviations

1: Key Finding 1
2: Key Finding 2
3: Key Finding 3
4: Key Finding 5
5: Key Finding 6
6: Key Finding 7
7: Key Finding 8
8: Parent market
9: Market characteristics
10: Offerings of vendors included in the market definition
11: Market segments
12: Global - Market size and forecast 2020 - 2025 ($ million)
13: Global market: Year-over-year growth 2020 - 2025 (%)
14: Five forces analysis 2020 & 2025
15: Bargaining power of buyers
16: Bargaining power of suppliers
17: Threat of new entrants
18: Threat of substitutes
19: Threat of rivalry
20: Market condition - Five forces 2020
21: Type - Market share 2020-2025 (%)
22: Comparison by Type
23: Biologics - Market size and forecast 2020-2025 ($ million)
24: Biologics - Year-over-year growth 2020-2025 (%)
25: Small molecules - Market size and forecast 2020-2025 ($ million)
26: Small molecules - Year-over-year growth 2020-2025 (%)
27: Market opportunity by Type
28: Customer landscape
29: Market share By Geographical Landscape 2020-2025 (%)
30: Geographic comparison
31: North America - Market size and forecast 2020-2025 ($ million)
32: North America - Year-over-year growth 2020-2025 (%)
33: Europe - Market size and forecast 2020-2025 ($ million)
34: Europe - Year-over-year growth 2020-2025 (%)
35: Asia - Market size and forecast 2020-2025 ($ million)
36: Asia - Year-over-year growth 2020-2025 (%)
37: ROW - Market size and forecast 2020-2025 ($ million)
38: ROW - Year-over-year growth 2020-2025 (%)
39: Key leading countries
40: Market opportunity By Geographical Landscape ($ million)
41: Impact of drivers and challenges
42: Vendor landscape
43: Landscape disruption
44: Industry risks
45: Vendors covered
46: Market positioning of vendors
47: AFM-Telethon - Overview
48: AFM-Telethon - Product and service
49: AFM-Telethon - Key offerings
50: AFM-Telethon - Key customers
51: AFM-Telethon - Segment focus
52: Biogen Inc. - Overview
53: Biogen Inc. - Business segments
54: Biogen Inc. - Key offerings
55: Biogen Inc. - Key customers
56: Biogen Inc. - Segment focus
57: Brainstorm Cell Therapeutics Inc. - Overview
58: Brainstorm Cell Therapeutics Inc. - Product and service
59: Brainstorm Cell Therapeutics Inc. - Key offerings
60: Brainstorm Cell Therapeutics Inc. - Key customers
61: Brainstorm Cell Therapeutics Inc. - Segment focus
62: F. Hoffmann-La Roche Ltd. - Overview
63: F. Hoffmann-La Roche Ltd. - Business segments
64: F. Hoffmann-La Roche Ltd. - Key offerings
65: F. Hoffmann-La Roche Ltd. - Key customers
66: F. Hoffmann-La Roche Ltd. - Segment focus
67: Mitsubishi Chemical Holdings Corp. - Overview
68: Mitsubishi Chemical Holdings Corp. - Business segments
69: Mitsubishi Chemical Holdings Corp. - Key offerings
70: Mitsubishi Chemical Holdings Corp. - Key customers
71: Mitsubishi Chemical Holdings Corp. - Segment focus
72: Novartis AG - Overview
73: Novartis AG - Business segments
74: Novartis AG - Key offerings
75: Novartis AG - Key customers
76: Novartis AG - Segment focus
77: Pfizer Inc. - Overview
78: Pfizer Inc. - Business segments
79: Pfizer Inc. - Key offerings
80: Pfizer Inc. - Key customers
81: Pfizer Inc. - Segment focus
82: PTC Therapeutics Inc. - Overview
83: PTC Therapeutics Inc. - Business segments
84: PTC Therapeutics Inc. - Key offerings
85: PTC Therapeutics Inc. - Key customers
86: PTC Therapeutics Inc. - Segment focus
87: Sanofi SA - Overview
88: Sanofi SA - Business segments
89: Sanofi SA - Key offerings
90: Sanofi SA - Key customers
91: Sanofi SA - Segment focus
92: Sarepta Therapeutics Inc. - Overview
93: Sarepta Therapeutics Inc. - Business segments
94: Sarepta Therapeutics Inc. - Key offerings
95: Sarepta Therapeutics Inc. - Key customers
96: Sarepta Therapeutics Inc. - Segment focus
97: Currency conversion rates for US$
98: Research Methodology
99: Validation techniques employed for market sizing
100: Information sources
101: List of abbreviations